RegInfo: The international database of regulated information of listed companies

SEARCH BY

Issuer directory

KEYWORDS

COMPANIES / ISIN

TYPE OF INFORMATION

INDUSTRY

ADVANCED SEARCH

COMPARTMENTS / INDICES

France

America

Asia

Oceania

> ASX 20
Australia - ASX 20
> NZX 15
New Zealand - NZX 15

Africa

> FTSE/JSE...
South Africa - FTSE/JSE Top 40
> TA 25
Israel - TA 25
- ALONY HETZ
- AZRIELI GROUP
- BAZAN
- BEZEQ
- DELEK DRILLIN
- DISCOUNT
- ELBIT SYSTEMS
- FIBI BANK
- FRUTAROM
- GAZIT GLOBE
- HAREL
- ICL
- ISRAEL CORP
- LEUMI
- MAZOR ROBOTICS
- MIZRAHI TEFAHOT
- NICE
- OPKO HEALTH
- ORMAT
- PAZ OIL
- PERRIGO
- POALIM
- SHUFERSAL
- SODASTREAM
- STRAUSS GROUP
- TEVA
- TOWER JAZZ

Europe

PERIODIC INFORMATION

ANNUAL FINANCIAL REPORT	HALF-YEAR FINANCIAL	QUARTERLY INFORMATION
Tonnellerie François Frères S.A. Auckland International Airport Vector Limited	Alten AMUNDI AMUNDI	SII (Société pour l'Informatique Industrielle) Bains de Mer et du Cercle des Etrangers à Monaco GENERIX
More documents (16842)	More documents (18016)	More documents (31788)
REGISTRATION DOCUMENT	20F	STATUTORY AUDITORS C
Dalet S.A. ATARI GENERIX	Wipro Ltd. Infosys Technologies Ltd MAZOR ROBOTICS	Grands Moulins de Strasbourg Burelle S.A. CRCAM Alpes Provence
More documents (5714)	More documents (453)	More documents (1722)
AGM	INTERNAL CONTROL	ANNUAL INFO MEMO ART
Bains de Mer et du Cercle des Etrangers à Monaco Latvijas Gaze Zublin Immobiliere	Orion TARKETT TARKETT	Exacompta Clairefontaine S.A. Crédit Agricole de la Touraine et du Poitou TIVOLY
More documents (11576)	More documents (2106)	More documents (1309)

PERMANENT INFORMATION

2018.09.22 | 14:41 | Permanent Information Releases / General Company News

NOVARTIS

Novartis to file for new Lucentis® (ranibizumab) indication in retinopathy of prematurity (ROP), a rare disease in premature infants that often leads to blindness - HTML (w)

2018.09.22 | 14:36 | Permanent Information Releases / General Company News

NOVARTIS

New analysis of Novartis Phase III brolucizumab (RTH258) data reinforces superior reduction of retinal fluid, a key marker of disease activity in nAMD - HTML (w)

2018.09.21 | 22:18 | Permanent Information Releases / General Company News

DASSAULT AVIATION

Dassault Aviation : A propos du contrat Rafale en Inde - HTML (w)

2018.09.21 | 22:18 | Permanent Information Releases / General Company News

DASSAULT AVIATION

Dassault Aviation: About the Rafale contract for India - HTML (w)

2018.09.21 | 21:16 | Permanent Information Releases / General Company News

GENMAB

Grant of Restricted Stock Units and Warrants to Genmab employees - HTML (w)

More documents (268346)

Financial transactions

2018.09.22 | 14:41 | Permanent Information Releases / General Company News

NOVARTIS

Novartis to file for new Lucentis® (ranibizumab) indication in retinopathy of prematurity (ROP), a rare disease in premature infants that often leads to blindness - HTML (w)

2018.09.22 | 14:36 | Permanent Information Releases / General Company News

NOVARTIS

New analysis of Novartis Phase III brolucizumab (RTH258) data reinforces superior reduction of retinal fluid, a key marker of disease activity in nAMD - HTML (w)

2018.09.21 | 22:18 | Permanent Information Releases / General Company News

DASSAULT AVIATION

Dassault Aviation : A propos du contrat Rafale en Inde - HTML (w)

2018.09.21 | 22:18 | Permanent Information Releases / General Company News

DASSAULT AVIATION

Dassault Aviation: About the Rafale contract for India - HTML (w)

2018.09.21 | 21:16 | Permanent Information Releases / General Company News

GENMAB

Grant of Restricted Stock Units and Warrants to Genmab employees - HTML (w)

More documents (5320)